drugset / Trial / NCT04155567

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants

NCT04155567 ↗

Phase 1 Completed 10 enrolled Takeda
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the PK, safety and tolerability of phenylacetate and benzoate after intravenous administration of TAK-123 in Japanese healthy adult male participants.

Timeline

Start
2019-11-13
Primary completion
2019-12-06
Completion
2019-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject TAK-123 Unknown 3.75 g Intravenous

Indications

No indication recorded.